| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0086 | 0.9 |